Precise Health starts CHF 900,000 Innosuisse project to speed AI phage matching

Precise Health SA, a Biopôle-based EPFL spin-out, has kicked off an Innosuisse Innovation Project worth approximately CHF 900,000 with the University of Geneva and Geneva University Hospitals (HUG). The project builds on its AI-powered PhageMatch platform and will explore how rapid bacterial characterisation combined with AI-driven phage matching can shorten the time needed to source the right phage for a patient.